21,951 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Bought by Avanza Fonder AB

Avanza Fonder AB acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 21,951 shares of the medical device company’s stock, valued at approximately $2,018,000.

Several other large investors also recently modified their holdings of the business. Victory Capital Management Inc. boosted its holdings in Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after purchasing an additional 737,726 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Cooper Companies by 194.0% during the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after buying an additional 32,260 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Cooper Companies by 6.6% during the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after buying an additional 14,687 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after buying an additional 573,908 shares during the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in Cooper Companies by 60.9% in the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 38,065 shares of the medical device company’s stock valued at $3,323,000 after acquiring an additional 14,413 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

COO has been the subject of several research analyst reports. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Citigroup cut their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Finally, Morgan Stanley decreased their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Trading Up 1.3 %

Cooper Companies stock opened at $93.27 on Friday. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $18.61 billion, a price-to-earnings ratio of 47.83, a PEG ratio of 2.29 and a beta of 0.99. The firm has a 50-day moving average price of $96.54 and a two-hundred day moving average price of $98.98.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.